BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6282057)

  • 1. Adaptive changes as the mode of action of antidepressant treatments.
    Vetulani J
    Adv Biochem Psychopharmacol; 1982; 31():27-36. PubMed ID: 6282057
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of antidepressant neuroleptics, chlorprothixene and levomepromazine, on the central noradrenergic system: comparison with other antidepressants.
    Antkiewicz-Michaluk L
    Pol J Pharmacol Pharm; 1985; 37(5):673-83. PubMed ID: 3008133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of chronic treatment with antidepressant neuroleptics on the central serotonin system.
    Antkiewicz-Michaluk L
    Pol J Pharmacol Pharm; 1986; 38(4):359-70. PubMed ID: 3774629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive changes in functions of brain neurotransmitter receptors, evoked by repeated administration of antidepressant drugs.
    Przegaliński E
    Acta Physiol Pol; 1987; 38(5):373-85. PubMed ID: 2839008
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the neurochemical basis of action of antidepressant drugs and electroconvulsive treatment.
    Vetulani J
    Pol J Pharmacol Pharm; 1984; 36(2-3):101-15. PubMed ID: 6089155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic treatment with tricyclic antidepressant drugs on identified brain noradrenergic and serotonergic neurons.
    Svensson TH
    Acta Psychiatr Scand Suppl; 1980; 280():121-31. PubMed ID: 6250320
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase in rat cortical [3H]naloxone binding site density after chronic administration of antidepressant agents.
    Antkiewicz-Michaluk L; Rokosz-Pelc A; Vetulani J
    Eur J Pharmacol; 1984 Jun; 102(1):179-81. PubMed ID: 6090155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution to the pharmacology of antidepressants of tricyclic structure. (Review)].
    Polezhaeva AI
    Farmakol Toksikol; 1967; 30(2):243-9. PubMed ID: 4177249
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of the serotonergic system in the mode of action of the new potential antidepressant agent 5-methoxyindolyl-2-methylamine.
    Carranza Gómez-Carpintero MC; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Aug; 43(8):809-13. PubMed ID: 8216432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mode of action of mianserin.
    Leonard BE
    Adv Biochem Psychopharmacol; 1982; 31():301-19. PubMed ID: 6282060
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidepressant drug action and presynaptic alpha-receptors.
    Collis MG; Shepherd JT
    Mayo Clin Proc; 1980 Sep; 55(9):567-72. PubMed ID: 6251322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of antidepressant drugs increases the density of cortical [3H]prazosin binding sites in the rat.
    Vetulani J; Antkiewicz-Michaluk L; Rokosz-Pelc A
    Brain Res; 1984 Sep; 310(2):360-2. PubMed ID: 6148998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of antidepressants on the central effects of serotonin and noradreanline].
    Allikmets LKh; Vakhing VA
    Farmakol Toksikol; 1972; 35(6):649-53. PubMed ID: 4651792
    [No Abstract]   [Full Text] [Related]  

  • 14. The mode of action of tricyclic antidepressants: a brief review of recent progress.
    Horn AS
    Postgrad Med J; 1980; 56 Suppl 1():9-12. PubMed ID: 6248847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of antidepressants and neuroleptics on emotional reactions caused by cholinergic stimulation of the hypothalamus and mesencephalon].
    Vakhing VA; Allikmets LKh; Mekhilane LS
    Farmakol Toksikol; 1972 Jul; 35(4):398-401. PubMed ID: 5065707
    [No Abstract]   [Full Text] [Related]  

  • 16. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
    Paul IA; Nowak G; Layer RT; Popik P; Skolnick P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):95-102. PubMed ID: 8169857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of antidepressants at the synapse: focus on newer compounds.
    Richelson E
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():34-9; discussion 40-1, 98-100. PubMed ID: 7961541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of adrenocorticotropin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function.
    Kendall DA; Duman R; Slopis J; Enna SJ
    J Pharmacol Exp Ther; 1982 Sep; 222(3):566-71. PubMed ID: 6286924
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidepressants and endogenous opioid peptide systems.
    Przewłocki R; Lasoń W; Majeed NH; Przewłocka B
    Neuropeptides; 1985 Feb; 5(4-6):575-8. PubMed ID: 3858703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of antidepressant drugs and electroconvulsive shock (ECS) on cortical alpha 1-adrenoceptors following destruction of dopaminergic nerve terminals.
    Nowak G
    Pharmacol Toxicol; 1989 May; 64(5):469-70. PubMed ID: 2549530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.